7 Common and Serious Side Effects of Airsupra
Meta Description: Learn about the 7 common and serious side effects of Airsupra and how to manage risks like oral thrush or heart issues through proper inhaler [...]
Read More
Medically reviewed by Jerome Albert Ecker | MD, Assistant Professor of Medicine, Duke University - Durham, NC on June 24th, 2024.
Buprenorphine is a partial opioid agonist that reduces overdose deaths by 50% when initiated in emergency departments, providing safer treatment than full agonists like methadone.
Emergency room initiation bypasses typical waiting periods for addiction treatment, allowing patients to start sublingual tablets (2-8mg daily) immediately during crisis situations.
Prescribing requires special DEA X-waiver licensing, with initial limits of 30 patients that can expand to 275 after training—creating significant access barriers in many hospitals.
Withdrawal symptoms peak 12-30 hours after last opioid use; timing matters because starting too early can precipitate severe withdrawal due to the medication's unique binding properties.
Monthly injectable formulations (Sublocade) eliminate daily dosing compliance issues but require stabilization on sublingual forms for at least 7 days first.
The opioid epidemic has been devastating communities across the nation, claiming countless lives and leaving families shattered. In the face of this crisis, it's crucial that we remove barriers for physicians to treat addiction effectively. The emergency room (ER) is a critical point of intervention, where countless individuals suffering from opioid addiction can be reached and offered a path to recovery through buprenorphine treatment.
Buprenorphine, also known as Subutex or Suboxone, is a medication used in medication-assisted treatment (MAT) for opioid addiction. As a partial opioid agonist, buprenorphine partially stimulates the opioid receptors in the brain, reducing cravings and withdrawal symptoms without producing the same intense high as other opioids. This "ceiling effect" makes it much harder to overdose on buprenorphine compared to other opioids.
Studies have shown that buprenorphine treatment can:
Cut overdose deaths in half
Help people resume productive and fulfilling lives
Increase engagement in addiction treatment
Reduce illicit opioid use
Decrease the need for inpatient addiction treatment services
Despite the proven effectiveness of buprenorphine treatment, many barriers prevent physicians from prescribing it in the ER, including:
The need for an 8-hour training and a special DEA license (buprenorphine waiver)
Potential DEA audits and oversight
Patient limits set by the DEA
Time-consuming and frustrating nature of treating addiction
Stigma and bias towards patients with substance use disorders
To encourage more ER physicians to prescribe buprenorphine, we must provide them with the necessary resources and support. This can include:
Addiction consult teams with recovery coaches and navigators
Streamlined processes for follow-up care and referrals
Reducing the stigma surrounding addiction through education and awareness
By making it easier for ER physicians to prescribe buprenorphine and ensuring a smooth transition to long-term care, we can create a powerful pipeline from overdose to recovery. Everyone deserves a chance at a new life, and the ER is a critical entry point for this lifesaving treatment.
For more information on buprenorphine treatment and the opioid epidemic, visit:
Emergency departments offer a critical window to begin life-saving opioid addiction treatment when patients are most motivated to change. Starting within the first 24-48 hours of withdrawal can prevent patients from leaving against medical advice to use street drugs. If you're experiencing withdrawal symptoms or seeking addiction treatment options, Doctronic can help connect you with immediate medical guidance.
Meta Description: Learn about the 7 common and serious side effects of Airsupra and how to manage risks like oral thrush or heart issues through proper inhaler [...]
Read MoreMeta Description: Learn about 8 budesonide interactions and what to avoid when you’re taking budesonide, including grapefruit and common drugs, to ensure your treatment is [...]
Read MoreMeta Description: Learn about these 7 Xolair interactions and what to avoid when you’re taking Xolair to safely manage your asthma, chronic hives, or nasal polyp [...]
Read More